Insider · CIK 0001317093

Lanza Robert

Reports to the SEC for 1 company · WORCHESTER, MA

sec.gov

Transactions

Companies

Filings

CIK

0001317093

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-02-10	Ocata Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−76.7K sh	—	—	0
2016-02-10	Ocata Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−40K sh	—	—	0
2016-02-10	Ocata Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−12.9K sh	—	—	0
2016-02-10	Ocata Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−17.8K sh	—	—	0
2016-02-10	Ocata Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−53.5K sh	—	—	0
2016-02-10	Ocata Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−35.3K sh	—	—	0
2016-02-10	Ocata Therapeutics, Inc.U Disposition from Tender	Chief Scientific Officer	UDisposition from Tender	−232K sh	$8.50	−$1.97M	0
2016-02-10	Ocata Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−150K sh	—	—	0
2015-11-10	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$8.36	−$83.6K	196,509
2015-11-10	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−15K sh	$8.25	−$124K	216,509
2015-11-10	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$8.36	−$83.6K	206,509
2014-09-12	Ocata Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+112K sh	—	—	112,000
2014-09-12	Ocata Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+56K sh	—	—	231,509
2014-09-12	Ocata Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+112K sh	—	—	124,858
2014-09-10	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$12.50	−$62.5K	179,439
2014-09-10	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,930 sh	$12.57	−$49.4K	175,509
2014-09-08	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$10.00	−$50K	194,439
2014-09-08	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$10.07	−$101K	184,439
2014-09-03	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$9.00	−$90K	199,439
2014-09-02	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$9.01	−$45.1K	209,439
2014-09-02	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$8.12	−$81.2K	214,439
2014-07-07	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−745K sh	$0.08	−$59.6K	22,443,822
2014-07-03	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−755K sh	$0.08	−$60.4K	23,188,822
2013-11-08	Ocata Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+1.29M sh	—	—	1,285,714
2013-11-08	Ocata Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	−1.29M sh	—	—	23,943,822
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−440K sh	$0.06	−$25.5K	23,497,575
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−43K sh	$0.06	−$2,580	22,619,085
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−150K sh	$0.06	−$8,895	22,762,085
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−545K sh	$0.06	−$32.2K	22,912,085
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−100K sh	$0.06	−$5,940	22,662,085
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−40K sh	$0.06	−$2,340	23,457,575
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−40K sh	$0.06	−$2,340	27,314,717
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−43K sh	$0.06	−$2,580	26,476,227
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−100K sh	$0.06	−$5,940	26,519,227
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−150K sh	$0.06	−$8,895	26,619,227
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−545K sh	$0.06	−$32.2K	26,769,227
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−440K sh	$0.06	−$25.5K	27,354,717
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−20K sh	$0.06	−$1,158	27,794,717
2012-12-14	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−20K sh	$0.06	−$1,158	23,937,575
2012-09-28	Ocata Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+1.29M sh	—	—	27,814,717
2012-07-31	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−500K sh	$0.08	−$40K	26,529,003
2012-07-30	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−152K sh	$0.08	−$12.1K	27,765,796
2012-07-30	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−612K sh	$0.08	−$48.9K	27,917,296
2012-07-30	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−547K sh	$0.08	−$44.3K	27,219,003
2012-07-30	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−190K sh	$0.08	−$15.6K	27,029,003
2012-06-29	Ocata Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+1.29M sh	—	—	28,529,003
2012-03-30	Ocata Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+1.29M sh	—	—	27,243,289
2012-01-24	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6.66M sh	$0.19	−$1.28M	25,957,575
2012-01-23	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1M sh	$0.18	−$175K	32,615,875
2011-09-29	Ocata Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−608K sh	$0.15	−$93.1K	33,615,875

Recent filings

Accepted (ET)
Feb 114
Ocata Therapeutics, Inc.0001104659-16-095976
SEC(opens sec.gov)
Nov 104
Ocata Therapeutics, Inc.0001179110-15-014694
SEC(opens sec.gov)
Sep 184/A
ADVANCED CELL TECHNOLOGY, INC.0001179110-14-014283
SEC(opens sec.gov)
Sep 164
ADVANCED CELL TECHNOLOGY, INC.0001179110-14-014206
SEC(opens sec.gov)
Sep 114
ADVANCED CELL TECHNOLOGY, INC.0001179110-14-014077
SEC(opens sec.gov)
Sep 94
ADVANCED CELL TECHNOLOGY, INC.0001179110-14-013837
SEC(opens sec.gov)
Sep 44
ADVANCED CELL TECHNOLOGY, INC.0001179110-14-013684
SEC(opens sec.gov)

Companies

Ocata Therapeutics, Inc.Chief Scientific Officer

Address

381 PLANTATION STREET

WORCHESTER, MA, 01605